Turn.bio Company

Turn Biotechnologies develops mRNA medicines that induce the body to heal itself by instructing specific cells to fight disease or repair damaged tissue. We are focused on reprogramming the epigenome – a network of chemical compounds and proteins that control cell functions by influencing which genes are active – to restore capabilities that are often lost with age.
Industry: Biotechnology, Gene therapy, Genetics, Health Care, Therapeutics
Headquarters: Mountain View, California, United States
Founded Date: Feb 2019
Employees Number: 1-10
Funding Status: Seed
Investors Number: 5
Estimated Revenue: Less than $1M
Last Funding Date: Apr 28, 2021
Last Funding Type: Funding Round

Visit Website
info@turn.bio
https://twitter.com/turn_bio
Register and Claim Ownership